ID   ASPG2_ECOLI             Reviewed;         348 AA.
AC   P00805; Q2M9N6;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1990, sequence version 2.
DT   15-MAR-2017, entry version 163.
DE   RecName: Full=L-asparaginase 2;
DE            EC=3.5.1.1;
DE   AltName: Full=L-asparaginase II;
DE            Short=L-ASNase II;
DE   AltName: Full=L-asparagine amidohydrolase II;
DE   AltName: INN=Colaspase;
DE   Flags: Precursor;
GN   Name=ansB; OrderedLocusNames=b2957, JW2924;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2407723; DOI=10.1128/jb.172.3.1491-1498.1990;
RA   Jennings M.P., Beacham I.R.;
RT   "Analysis of the Escherichia coli gene encoding L-asparaginase II,
RT   ansB, and its regulation by cyclic AMP receptor and FNR proteins.";
RL   J. Bacteriol. 172:1491-1498(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12;
RX   PubMed=2144836; DOI=10.1016/0378-1119(90)90168-Q;
RA   Bonthron D.T.;
RT   "L-asparaginase II of Escherichia coli K-12: cloning, mapping and
RT   sequencing of the ansB gene.";
RL   Gene 91:101-105(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [5]
RP   PROTEIN SEQUENCE OF 23-348.
RX   PubMed=6766894;
RA   Maita T., Matsuda G.;
RT   "The primary structure of L-asparaginase from Escherichia coli.";
RL   Hoppe-Seyler's Z. Physiol. Chem. 361:105-117(1980).
RN   [6]
RP   PARTIAL PROTEIN SEQUENCE.
RX   PubMed=387570;
RA   Maita T., Morokuma K., Matsuda G.;
RT   "Amino acid sequences of the tryptic peptides from carboxymethylated
RT   L-asparaginase from Escherichia coli.";
RL   Hoppe-Seyler's Z. Physiol. Chem. 360:1483-1495(1979).
RN   [7]
RP   ACTIVE SITE.
RX   PubMed=321449;
RA   Peterson R.G., Richards F.F., Handschumacher R.E.;
RT   "Structure of peptide from active site region of Escherichia coli L-
RT   asparaginase.";
RL   J. Biol. Chem. 252:2072-2076(1977).
RN   [8]
RP   SUBUNIT.
RX   PubMed=4561256; DOI=10.1016/0003-9861(72)90216-0;
RA   Greenquist A.C., Wriston J.C. Jr.;
RT   "Chemical evidence for identical subunits in L-asparaginase from
RT   Escherichia coli B.";
RL   Arch. Biochem. Biophys. 152:280-286(1972).
RN   [9]
RP   ACTIVE SITE THR-34, MUTAGENESIS OF THR-34, AND SUBUNIT.
RX   PubMed=1906013; DOI=10.1016/0014-5793(91)80723-G;
RA   Harms E., Wehner A., Aung H.P., Roehm K.H.;
RT   "A catalytic role for threonine-12 of E. coli asparaginase II as
RT   established by site-directed mutagenesis.";
RL   FEBS Lett. 285:55-58(1991).
RN   [10]
RP   MUTAGENESIS OF HISTIDINE RESIDUES.
RX   PubMed=1521538; DOI=10.1111/j.1432-1033.1992.tb17210.x;
RA   Wehner A., Harms E., Jennings M.P., Beacham I.R., Derst C., Bast P.,
RA   Roehm K.H.;
RT   "Site-specific mutagenesis of Escherichia coli asparaginase II. None
RT   of the three histidine residues is required for catalysis.";
RL   Eur. J. Biochem. 208:475-480(1992).
RN   [11]
RP   MUTAGENESIS OF THREONINE AND SERINE RESIDUES.
RX   PubMed=1287659; DOI=10.1093/protein/5.8.785;
RA   Ders C., Henseling J., Roehm K.H.;
RT   "Probing the role of threonine and serine residues of E. coli
RT   asparaginase II by site-specific mutagenesis.";
RL   Protein Eng. 5:785-789(1992).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) IN COMPLEX WITH ASPARTIC ACID,
RP   DISULFIDE BOND, AND SUBUNIT.
RX   PubMed=8434007; DOI=10.1073/pnas.90.4.1474;
RA   Swain A.L., Jaskolski M., Housset D., Rao J.K.M., Wlodawer A.;
RT   "Crystal structure of Escherichia coli L-asparaginase, an enzyme used
RT   in cancer therapy.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:1474-1478(1993).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF MUTANT VAL-111, ACTIVE SITE,
RP   MUTAGENESIS OF THR-111, CATALYTIC ACTIVITY, SUBUNIT, AND DISULFIDE
RP   BOND.
RX   PubMed=8706862; DOI=10.1016/0014-5793(96)00660-6;
RA   Palm G.J., Lubkowski J., Derst C., Schleper S., Roehm K.H.,
RA   Wlodawer A.;
RT   "A covalently bound catalytic intermediate in Escherichia coli
RT   asparaginase: crystal structure of a Thr-89-Val mutant.";
RL   FEBS Lett. 390:211-216(1996).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 23-348 IN COMPLEXES WITH
RP   ASPARTIC ACID, AND SUBUNIT.
RX   PubMed=12595697; DOI=10.1107/S0907444902021200;
RA   Sanches M., Barbosa J.A., de Oliveira R.T., Abrahao Neto J.,
RA   Polikarpov I.;
RT   "Structural comparison of Escherichia coli L-asparaginase in two
RT   monoclinic space groups.";
RL   Acta Crystallogr. D 59:416-422(2003).
CC   -!- CATALYTIC ACTIVITY: L-asparagine + H(2)O = L-aspartate + NH(3).
CC       {ECO:0000269|PubMed:8706862}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.115 uM for L-asparagine;
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:12595697,
CC       ECO:0000269|PubMed:1906013, ECO:0000269|PubMed:4561256,
CC       ECO:0000269|PubMed:8434007, ECO:0000269|PubMed:8706862}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-907458, EBI-907458;
CC   -!- SUBCELLULAR LOCATION: Periplasm.
CC   -!- INDUCTION: By cAMP and anaerobiosis.
CC   -!- PHARMACEUTICAL: Available under the names Crastinin (Bayer),
CC       Elspar (Merck), Kidrolase (Rhone-Poulenc) and Leunase (Kyowa).
CC       Also available as a PEG-conjugated form (Pegaspargase) under the
CC       name Oncaspar (Enzon). Used as an antineoplastic in chemotherapy.
CC       Reduces the quantity of asparagine available to cancer cells.
CC   -!- MISCELLANEOUS: E.coli contains two L-asparaginase isoenzymes: L-
CC       asparaginase I, a low-affinity enzyme located in the cytoplasm,
CC       and L-asparaginase II, a high-affinity secreted enzyme.
CC   -!- SIMILARITY: Belongs to the asparaginase 1 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Worthington enzyme manual;
CC       URL="http://www.worthington-biochem.com/ASPR/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M34277; AAA24062.1; -; Genomic_DNA.
DR   EMBL; M34234; AAA23445.1; -; Genomic_DNA.
DR   EMBL; U28377; AAA69124.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC75994.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAE77020.1; -; Genomic_DNA.
DR   PIR; A35132; XDEC.
DR   RefSeq; NP_417432.1; NC_000913.3.
DR   RefSeq; WP_000394140.1; NZ_LN832404.1.
DR   PDB; 1HO3; X-ray; 2.50 A; A/B=23-348.
DR   PDB; 1IHD; X-ray; 2.65 A; A/C=23-348.
DR   PDB; 1JAZ; X-ray; 2.27 A; A/B=23-348.
DR   PDB; 1JJA; X-ray; 2.30 A; A/B/C/D/E/F=23-348.
DR   PDB; 1NNS; X-ray; 1.95 A; A/B=23-348.
DR   PDB; 3ECA; X-ray; 2.40 A; A/B/C/D=23-348.
DR   PDB; 4ECA; X-ray; 2.20 A; A/B/C/D=23-348.
DR   PDBsum; 1HO3; -.
DR   PDBsum; 1IHD; -.
DR   PDBsum; 1JAZ; -.
DR   PDBsum; 1JJA; -.
DR   PDBsum; 1NNS; -.
DR   PDBsum; 3ECA; -.
DR   PDBsum; 4ECA; -.
DR   ProteinModelPortal; P00805; -.
DR   SMR; P00805; -.
DR   BioGrid; 4259243; 248.
DR   DIP; DIP-9110N; -.
DR   IntAct; P00805; 7.
DR   STRING; 511145.b2957; -.
DR   DrugBank; DB01817; Threonine-Aspartic Ester.
DR   Allergome; 8365; Esc c Asparaginase.
DR   PaxDb; P00805; -.
DR   PRIDE; P00805; -.
DR   EnsemblBacteria; AAC75994; AAC75994; b2957.
DR   EnsemblBacteria; BAE77020; BAE77020; BAE77020.
DR   GeneID; 947454; -.
DR   KEGG; ecj:JW2924; -.
DR   KEGG; eco:b2957; -.
DR   PATRIC; 32121326; VBIEscCol129921_3051.
DR   EchoBASE; EB0044; -.
DR   EcoGene; EG10046; ansB.
DR   eggNOG; ENOG4105HDK; Bacteria.
DR   eggNOG; COG0252; LUCA.
DR   HOGENOM; HOG000044165; -.
DR   InParanoid; P00805; -.
DR   KO; K01424; -.
DR   OMA; NFGPLGY; -.
DR   PhylomeDB; P00805; -.
DR   BioCyc; EcoCyc:ANSB-MONOMER; -.
DR   BioCyc; MetaCyc:ANSB-MONOMER; -.
DR   BRENDA; 3.5.1.1; 2026.
DR   SABIO-RK; P00805; -.
DR   EvolutionaryTrace; P00805; -.
DR   PRO; PR:P00805; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0030288; C:outer membrane-bounded periplasmic space; IDA:EcoCyc.
DR   GO; GO:0042597; C:periplasmic space; ISM:EcoliWiki.
DR   GO; GO:0004067; F:asparaginase activity; IDA:EcoCyc.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0006530; P:asparagine catabolic process; IBA:GO_Central.
DR   GO; GO:0051289; P:protein homotetramerization; IDA:EcoCyc.
DR   Gene3D; 3.40.50.1170; -; 1.
DR   Gene3D; 3.40.50.40; -; 1.
DR   InterPro; IPR004550; AsnASE_II.
DR   InterPro; IPR006034; Asparaginase/glutaminase.
DR   InterPro; IPR020827; Asparaginase/glutaminase_AS1.
DR   InterPro; IPR027475; Asparaginase/glutaminase_AS2.
DR   InterPro; IPR027473; L-asparaginase_C.
DR   InterPro; IPR027474; L-asparaginase_N.
DR   Pfam; PF00710; Asparaginase; 1.
DR   PIRSF; PIRSF001220; L-ASNase_gatD; 1.
DR   PRINTS; PR00139; ASNGLNASE.
DR   SMART; SM00870; Asparaginase; 1.
DR   SUPFAM; SSF53774; SSF53774; 1.
DR   TIGRFAMs; TIGR00520; asnASE_II; 1.
DR   PROSITE; PS00144; ASN_GLN_ASE_1; 1.
DR   PROSITE; PS00917; ASN_GLN_ASE_2; 1.
DR   PROSITE; PS51732; ASN_GLN_ASE_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   Disulfide bond; Hydrolase; Periplasm; Pharmaceutical;
KW   Reference proteome; Signal.
FT   SIGNAL        1     22       {ECO:0000269|PubMed:6766894}.
FT   CHAIN        23    348       L-asparaginase 2.
FT                                /FTId=PRO_0000002356.
FT   DOMAIN       24    348       Asparaginase/glutaminase.
FT                                {ECO:0000255|PROSITE-ProRule:PRU01068}.
FT   REGION       80     81       Substrate binding.
FT   REGION      111    112       Substrate binding.
FT   ACT_SITE     34     34       O-isoaspartyl threonine intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10099,
FT                                ECO:0000255|PROSITE-ProRule:PRU10100,
FT                                ECO:0000269|PubMed:1906013}.
FT   DISULFID     99    127       {ECO:0000269|PubMed:8434007,
FT                                ECO:0000269|PubMed:8706862}.
FT   MUTAGEN      34     34       T->A: Loss of enzyme activity.
FT                                {ECO:0000269|PubMed:1906013}.
FT   MUTAGEN     111    111       T->S: Reduced enzyme activity.
FT                                {ECO:0000269|PubMed:8706862}.
FT   MUTAGEN     111    111       T->V: Loss of enzyme activity.
FT                                {ECO:0000269|PubMed:8706862}.
FT   CONFLICT     49     49       V -> A (in Ref. 5; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT     86     86       N -> D (in Ref. 5; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    132    132       Missing (in Ref. 5; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    156    156       Missing (in Ref. 5; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    171    171       Missing (in Ref. 5; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    206    206       N -> D (in Ref. 5; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    268    268       N -> D (in Ref. 5; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    274    274       S -> T (in Ref. 5; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    285    285       T -> D (in Ref. 5; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    290    290       Missing (in Ref. 5; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    330    330       Missing (in Ref. 5; AA sequence).
FT                                {ECO:0000305}.
FT   STRAND       25     33       {ECO:0000244|PDB:1NNS}.
FT   HELIX        34     36       {ECO:0000244|PDB:1NNS}.
FT   STRAND       42     44       {ECO:0000244|PDB:4ECA}.
FT   STRAND       48     50       {ECO:0000244|PDB:1NNS}.
FT   HELIX        54     59       {ECO:0000244|PDB:1NNS}.
FT   HELIX        62     66       {ECO:0000244|PDB:1NNS}.
FT   STRAND       69     78       {ECO:0000244|PDB:1NNS}.
FT   HELIX        80     82       {ECO:0000244|PDB:1NNS}.
FT   HELIX        85     98       {ECO:0000244|PDB:1NNS}.
FT   HELIX        99    101       {ECO:0000244|PDB:1NNS}.
FT   STRAND      103    108       {ECO:0000244|PDB:1NNS}.
FT   STRAND      111    113       {ECO:0000244|PDB:1NNS}.
FT   HELIX       114    124       {ECO:0000244|PDB:1NNS}.
FT   STRAND      131    134       {ECO:0000244|PDB:1NNS}.
FT   HELIX       147    159       {ECO:0000244|PDB:1NNS}.
FT   HELIX       161    163       {ECO:0000244|PDB:1NNS}.
FT   STRAND      168    172       {ECO:0000244|PDB:1NNS}.
FT   STRAND      175    178       {ECO:0000244|PDB:1NNS}.
FT   TURN        179    181       {ECO:0000244|PDB:1NNS}.
FT   STRAND      182    184       {ECO:0000244|PDB:1NNS}.
FT   STRAND      186    188       {ECO:0000244|PDB:4ECA}.
FT   STRAND      193    195       {ECO:0000244|PDB:1NNS}.
FT   TURN        196    198       {ECO:0000244|PDB:1NNS}.
FT   STRAND      201    205       {ECO:0000244|PDB:1NNS}.
FT   STRAND      208    211       {ECO:0000244|PDB:1NNS}.
FT   HELIX       220    222       {ECO:0000244|PDB:1NNS}.
FT   STRAND      236    240       {ECO:0000244|PDB:1NNS}.
FT   HELIX       248    255       {ECO:0000244|PDB:1NNS}.
FT   STRAND      259    266       {ECO:0000244|PDB:1NNS}.
FT   TURN        267    269       {ECO:0000244|PDB:1NNS}.
FT   HELIX       273    284       {ECO:0000244|PDB:1NNS}.
FT   STRAND      288    298       {ECO:0000244|PDB:1NNS}.
FT   STRAND      302    306       {ECO:0000244|PDB:1NNS}.
FT   HELIX       308    311       {ECO:0000244|PDB:1NNS}.
FT   STRAND      313    315       {ECO:0000244|PDB:1NNS}.
FT   HELIX       321    331       {ECO:0000244|PDB:1NNS}.
FT   TURN        332    334       {ECO:0000244|PDB:1NNS}.
FT   HELIX       338    345       {ECO:0000244|PDB:1NNS}.
SQ   SEQUENCE   348 AA;  36851 MW;  2076987C0E8B2F99 CRC64;
     MEFFKKTALA ALVMGFSGAA LALPNITILA TGGTIAGGGD SATKSNYTVG KVGVENLVNA
     VPQLKDIANV KGEQVVNIGS QDMNDNVWLT LAKKINTDCD KTDGFVITHG TDTMEETAYF
     LDLTVKCDKP VVMVGAMRPS TSMSADGPFN LYNAVVTAAD KASANRGVLV VMNDTVLDGR
     DVTKTNTTDV ATFKSVNYGP LGYIHNGKID YQRTPARKHT SDTPFDVSKL NELPKVGIVY
     NYANASDLPA KALVDAGYDG IVSAGVGNGN LYKSVFDTLA TAAKTGTAVV RSSRVPTGAT
     TQDAEVDDAK YGFVASGTLN PQKARVLLQL ALTQTKDPQQ IQQIFNQY
//
